Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions and Answers, 6798 [2011-2662]
Download as PDF
<![CDATA[
6798
Federal Register / Vol. 76, No. 26 / Tuesday, February 8, 2011 / Notices
the State operates on a July–June fiscal
year, or September 1 if the State
operates on a Federal fiscal year). No
specific format is required for the
intended use plan. The intended use of
SSBG funds—including the types of
activities to be supported and the
categories and characteristics of
individuals to be served—must be
provided. States vary greatly in the
information they provide and the
structure of the report. States are
required to submit a revised intended
use plan if the planned use of SSBG
funds changes during the year.
In order to provide a more accurate
analysis of the extent to which funds are
spent ‘‘in a manner consistent’’ with
each of the States’ plan for their use, as
required by 42 USC 1397e(a), we are
requesting that States voluntarily use
the format of the post-expenditure
reporting form to provide estimates of
the amount of expenditures and the
number of recipients, by service
category, that the State plans to use
SSBG funds to support as part of the
intended use plan. Many States are
already using the format of the postexpenditure reporting form as part of
their intended use plan.
Respondents:
The post-expenditure reporting form
and intended use plan are completed
once annually by a representative of the
agency that administers the Social
Services Block Grant at the State level
in each State.
Respondents:
State Governments
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Number of
responses per
respondent
Average
burden hours
per response
Total burden
hours
Post-Expenditure Reporting Form ...................................................................
Use of Post-Expenditure Reporting Form as Part of the Intended Use Plan
56
56
1
1
110
2
6,160
112
Estimated Total Annual Burden Hours: ....................................................
........................
........................
........................
6,272
Additional Information:
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be
identified by the title of the information
collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment:
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following:
srobinson on DSKHWCL6B1PROD with NOTICES
Office of Management and Budget,
Paperwork Reduction Project, Fax:
202–395–7285, E-mail: OIRA_
SUBMISSION@OMB.EOP.GOV,
Attn: Desk Officer for the
Administration for Children and
Families.
Dated: January 31, 2011.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011–2555 Filed 2–7–11; 8:45 am]
BILLING CODE 4184–01–M
VerDate Mar<15>2010
18:16 Feb 07, 2011
Jkt 223001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007–D–0429; Formerly Docket
No. 2007D–0496]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Labeling of Nonprescription Human
Drug Products Marketed Without an
Approved Application as Required by
the Dietary Supplement and
Nonprescription Drug Consumer
Protection Act: Questions and
Answers
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
Frm 00043
Fmt 4703
Dated: February 1, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–2662 Filed 2–7–11; 8:45 am]
The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Labeling of Nonprescription Human
Drug Products Marketed Without an
Approved Application as Required by
the Dietary Supplement and
Nonprescription Drug Consumer
Protection Act: Questions and Answers’’
has been approved by the Office of
Management and Budget (OMB) under
the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Berbakos, Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, 301–
796–3792,
Elizabeth.Berbakos@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of February 24, 2009
SUMMARY:
PO 00000
(74 FR 8264), the Agency announced
that the proposed information collection
had been submitted to OMB for review
and clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0640. The
approval expires on July 31, 2012. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.reginfo.gov/
public/do/PRAMain.
Sfmt 4703
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0049]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Presubmission
Conferences, New Animal Drug
Applications and Supporting
Regulations, and Food and Drug
Administration Form 356V
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
E:\FR\FM\08FEN1.SGM
Notice.
08FEN1
]]>Agencies
[Federal Register Volume 76, Number 26 (Tuesday, February 8, 2011)]
[Notices]
[Page 6798]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2662]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007-D-0429; Formerly Docket No. 2007D-0496]
Agency Information Collection Activities; Announcement of Office
of Management and Budget Approval; Labeling of Nonprescription Human
Drug Products Marketed Without an Approved Application as Required by
the Dietary Supplement and Nonprescription Drug Consumer Protection
Act: Questions and Answers
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
collection of information entitled ``Labeling of Nonprescription Human
Drug Products Marketed Without an Approved Application as Required by
the Dietary Supplement and Nonprescription Drug Consumer Protection
Act: Questions and Answers'' has been approved by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-3792,
Elizabeth.Berbakos@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the Federal Register of February 24, 2009
(74 FR 8264), the Agency announced that the proposed information
collection had been submitted to OMB for review and clearance under 44
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not
required to respond to, a collection of information unless it displays
a currently valid OMB control number. OMB has now approved the
information collection and has assigned OMB control number 0910-0640.
The approval expires on July 31, 2012. A copy of the supporting
statement for this information collection is available on the Internet
at https://www.reginfo.gov/public/do/PRAMain.
Dated: February 1, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-2662 Filed 2-7-11; 8:45 am]
BILLING CODE 4160-01-P
